144 related articles for article (PubMed ID: 7681554)
1. Tumor cell kinetics in elderly patients with cervical cancer.
Minagawa Y; Kigawa J; Kanamori Y; Itamochi H; Terakawa N
Obstet Gynecol; 1993 Apr; 81(4):610-4. PubMed ID: 7681554
[TBL] [Abstract][Full Text] [Related]
2. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
3. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometry (FCM) of early radiation response in epidermoid carcinoma of uterine cervix.
Glasová M; Siracký J; Masák L; Kysela B
Neoplasma; 1992; 39(6):353-6. PubMed ID: 1491725
[TBL] [Abstract][Full Text] [Related]
5. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
6. Prospective malignancy grading and flow cytometry DNA distribution in biopsy specimens from invasive squamous cell carcinoma of the uterine cervix.
Willén R; Tropé C; Långström E; Ranstam J; Killander D; Clase L
Anticancer Res; 1987; 7(2):235-42. PubMed ID: 3592637
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment proliferation parameters do not add predictive power to clinical factors in cervical cancer treated with definitive radiation therapy.
Tsang RW; Juvet S; Pintilie M; Hill RP; Wong CS; Milosevic M; Chapman W; Levin W; Manchul LA; Fykes AW
Clin Cancer Res; 2003 Oct; 9(12):4387-95. PubMed ID: 14555510
[TBL] [Abstract][Full Text] [Related]
8. [Flow cytometric analysis of DNA-ploidy in oral squamous cell carcinomas].
Wang XL
Zhonghua Kou Qiang Yi Xue Za Zhi; 1990 Jul; 25(4):210-2, 251-2. PubMed ID: 2128233
[TBL] [Abstract][Full Text] [Related]
9. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
Tachibana M; Miyakawa A; Nakamura K; Baba S; Murai M; Tazaki H
J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence-based analysis of DNA ploidy and cell proliferation within fine-needle samplings of breast tumors: a new approach using automated image cytometry.
Truong K; Vielh P; Malfoy B; Klijanienko J; Dutrillaux B; Bourgeois CA
Cancer; 1998 Oct; 84(5):309-16. PubMed ID: 9801206
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric evaluation of early invasive cervical cancer.
Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
[TBL] [Abstract][Full Text] [Related]
12. Polyclonal cervical tumors detected by flow cytometry.
Strang P; Stendahl U; Sorbe B
Anticancer Res; 1986; 6(2):171-5. PubMed ID: 3707052
[TBL] [Abstract][Full Text] [Related]
13. A ratio of apoptosis to mitosis, proliferation pattern and prediction of radiotherapy response in cervical carcinoma.
Gasinska A; Urbanski K; Gruchala A; Biesaga B; Kojs Z
Neoplasma; 2002; 49(6):379-86. PubMed ID: 12584585
[TBL] [Abstract][Full Text] [Related]
14. DNA content as prognostic factor in cervix carcinoma stage IB-III treated with radiotherapy.
Lutgens LC; Schutte B; de Jong JM; Thunnissen FB
Gynecol Oncol; 1994 Sep; 54(3):275-81. PubMed ID: 8088604
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometry in cervical adenocarcinoma. Correlating DNA content analysis with the clinical picture.
Kaspar HG; Dinh TV; Hannigan EV
J Reprod Med; 1997 Mar; 42(3):170-2. PubMed ID: 9109087
[TBL] [Abstract][Full Text] [Related]
16. Proliferative characteristics of primary and metastatic human solid tumors by DNA flow cytometry.
Frankfurt OS; Greco WR; Slocum HK; Arbuck SG; Gamarra M; Pavelic ZP; Rustum YM
Cytometry; 1984 Nov; 5(6):629-35. PubMed ID: 6518938
[TBL] [Abstract][Full Text] [Related]
17. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
18. Are increased tumor aneuploidy and heightened cell proliferation along with heterogeneity associated with patient outcome for carcinomas of the uterine cervix? A combined analysis of subjects treated in RTOG 9001 and a single-institution trial.
Wolfson AH; Winter K; Crook W; Krishan A; Grigsby PW; Markoe AM; Morris M; Gaffney DK; Eifel PJ; Lucci JA
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):111-7. PubMed ID: 17919835
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of DNA ploidy and cell proliferation activity in colorectal carcinoma.
Mazzei T; Tonelli F; Mini E; Mazzoni P; Pesciullesi A; Valanzano R; Ficari F; Biondi C; Periti P
Anticancer Res; 1995; 15(5B):2247-53. PubMed ID: 8572632
[TBL] [Abstract][Full Text] [Related]
20. [Cervix uteri cancer: determination of DNA content by means of cytophotometry].
Wistuba I; Roa I; Villaseca MA; Araya JC; Capurro I
Rev Med Chil; 1993 Aug; 121(8):873-9. PubMed ID: 8296094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
